Literature DB >> 11698996

ED management of cellulitis: a review of five urban centers.

S L Dong1, K D Kelly, R C Oland, B R Holroyd, B H Rowe.   

Abstract

Cellulitis is a common problem presenting to the emergency department (ED). This study examines the epidemiology of cellulitis in 5 Canadian urban EDs and determines the practice variation in this management among sites. From computerized provincial ED diagnosis information, 10% of cellulitis charts from April 1, 1997 to March 31, 1998 were randomly selected for review. All 5 EDs in one urban region were sampled; physicians were unaware of the study when seeing patients. A standardized audit form was used to collect information pertaining to visits for the incident infection case. Cases were excluded if simple cellulitis was not the primary diagnosis or if procedures such as incision and drainage were initially required. A total of 416 adult charts were retrospectively identified. The mean age was 46 years and 61% were men; 38% had seen another physician before the ED presentation. Cellulitis was most commonly located in the upper (41%) and lower (48%) extremities. Most cases were treated with intravenous cefazolin (58%; range among sites: 49%-66%); however, over 25 different antibiotics and doses were initially prescribed. Each case required a median of 4 (interquartile range [IQR]: 1, 9) ED visits. Some patients (14%) received an increase in dose (3%) or a change in antibiotic regimen (11%) during their treatment. Few patients (3%) required a second change in regimen. Specialist consultations were obtained in only 6% of patients and hospitalization was rare (7%). The most common discharge prescription was oral cephalexin (62%); however; many different regimens were prescribed. Cellulitis is a common ED problem which consumes considerable resources to treat. Considerable practice variation exists with respect to in-ED and post-ED management. These results suggest the need for the development of practice guidelines for the treatment of this common ED problem.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698996     DOI: 10.1053/ajem.2001.28330

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  18 in total

1.  Obesity and Heart Failure as Predictors of Failure in Outpatient Skin and Soft Tissue Infections.

Authors:  Erin L Conway; John A Sellick; Kari Kurtzhalts; Kari A Mergenhagen
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

2.  Emergency department management of home intravenous antibiotic therapy for cellulitis.

Authors:  M Donald; N Marlow; E Swinburn; M Wu
Journal:  Emerg Med J       Date:  2005-10       Impact factor: 2.740

3.  Clinical and molecular characteristics of invasive and noninvasive skin and soft tissue infections caused by group A Streptococcus.

Authors:  Jiun-Nong Lin; Lin-Li Chang; Chung-Hsu Lai; Hsi-Hsun Lin; Yen-Hsu Chen
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

4.  Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial.

Authors:  P Leman; D Mukherjee
Journal:  Emerg Med J       Date:  2005-05       Impact factor: 2.740

5.  Empirical antibiotics use in soft tissue infections.

Authors:  Rodger Shortt; Achilleas Thoma
Journal:  Can J Plast Surg       Date:  2008

6.  Cellulitis incidence in a defined population.

Authors:  S M Ellis Simonsen; E R van Orman; B E Hatch; S S Jones; L H Gren; K T Hegmann; J L Lyon
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

7.  Fluoroquinolone therapy for uncomplicated skin and skin structure infections : a retrospective database comparison of treatment duration, failures and charges.

Authors:  Karen N Keating; Howard Friedman; Eleanor M Perfetto
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

8.  Effect of Dermatology Consultation on Outcomes for Patients With Presumed Cellulitis: A Randomized Clinical Trial.

Authors:  Lauren N Ko; Anna C Garza-Mayers; Jessica St John; Lauren Strazzula; Priyanka Vedak; Radhika Shah; Allison S Dobry; Sowmya R Rao; Leslie W Milne; Blair Alden Parry; Daniela Kroshinsky
Journal:  JAMA Dermatol       Date:  2018-05-01       Impact factor: 10.282

9.  Is coverage of S. aureus necessary in cellulitis/erysipelas? A literature review.

Authors:  Stamatis Karakonstantis
Journal:  Infection       Date:  2019-12-16       Impact factor: 3.553

Review 10.  Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.

Authors:  Olatz Urbina; Olivia Ferrández; Mercè Espona; Esther Salas; Irene Ferrández; Santiago Grau
Journal:  Drug Des Devel Ther       Date:  2013-04-03       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.